ScholarIQanswers from OpenAlex

PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY

PaperCitations, authors & open-access status

PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY is a paper indexed in ScholarIQ from OpenAlex.

How many citations does PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY have?

ScholarIQcitation count

PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY has 91 citations in the OpenAlex counts ScholarIQ stores.

When was PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY published?

ScholarIQyear

PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY has 2001 year in the ScholarIQ index.

What is the open-access status of PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY?

ScholarIQoa status

PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY has closed oa status in the ScholarIQ index.

What is the DOI of PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY?

ScholarIQdoi

The DOI for PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY is on the source record.

What is the PMID of PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY?

ScholarIQpmid

The PMID for PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY is on the source record.

What is the OpenAlex record for PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY?

ScholarIQopenalex

The OpenAlex for PORT SITE TUMOR RECURRENCES OF RENAL CELL CARCINOMA AFTER VIDEOLAPAROSCOPIC RADICAL NEPHRECTOMY is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial